Stimulation of anxiety-like behavior via ERK pathway by competitive serotonin receptors 2A and 1A in post-Traumatic stress disordered mice

NeuroSignals

Volumn 25, Issue 1, 2018, Pages 39-53

  Xiang, Mingjun ^a,b   Jiang, Yuting ^a   Hu, Zhiying ^c   Yang, Yang ^a   Botchway, Benson O A ^a   Fang, Marong ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b JISHOU UNIVERSITY   (China)

^c Hangzhou Red Cross Hospital   (China)

Author keywords

5HT1AR; 5HT2AR; Anxiety like behavior; ERK pathway; Post Traumatic stress disorder

Indexed keywords

CRE RECOMBINASE; GENOMIC DNA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYC PROTEIN; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; CONTROLLED STUDY; ELEVATED PLUS MAZE TEST; FEAR; FREEZING; HIPPOCAMPUS; IMMUNOFLUORESCENCE; MALE; MOUSE; NONHUMAN; POSTTRAUMATIC STRESS DISORDER; PROTEIN EXPRESSION; PROTEIN EXPRESSION LEVEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; ANIMAL BEHAVIOR; DISEASE MODEL; MAPK SIGNALING; METABOLISM; PHYSIOLOGY; TRANSGENIC MOUSE;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; MAP KINASE SIGNALING SYSTEM; MICE; MICE, TRANSGENIC; RECEPTOR, SEROTONIN, 5-HT1A; RECEPTOR, SEROTONIN, 5-HT2A; STRESS DISORDERS, POST-TRAUMATIC;

EID: 85031401532     PISSN: 1424862X     EISSN: 14248638     Source Type: Journal    
DOI: 10.1159/000481791     Document Type: Article

References (49)

1. Lacivita E, Di Pilato P, De Giorgio P, Colabufo NA, Berardi F, Perrone R, Leopoldo M: The therapeutic potential of 5-HT1A receptors: A patent review. Expert Opin Ther Pat 2012;22:887-902.
2. Ursano RJ, Zhang L, Li H, Johnson L, Carlton J, Fullerton CS, Benedek DM: PTSD and traumatic stress from gene to community and bench to bedside. Brain Res 2009;1293:2-12.
3. Reul JM: Making memories of stressful events: A journey along epigenetic, gene transcription, and signaling pathways. Front Psychiatry 2014;5:5.
4. Kheirbek MA, Klemenhagen KC, Sahay A, Hen R: Neurogenesis and generalization: A new approach to stratify and treat anxiety disorders. Nat Neurosci 2012;15:1613-1620.
5. Meltzer HY, Li Z, Kaneda Y, Ichikawa J: Serotonin receptors: Their key role in drugs to treat schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2003;27:1159-1172.
6. McGaugh JL: The amygdala modulates the consolidation of memories of emotionally arousing experiences. Annu Rev Neurosci 2004;27:1-28.
7. Liu H, Wang HT, Han F, Shi YX: Activity of 5-HT1A receptor is involved in neuronal apoptosis of the amygdala in a rat model of post-Traumatic stress disorder. Mol Med Rep 2011;4:291-295.
8. Derangeon M, Bozon V, Defamie N, Peineau N, Bourmeyster N, Sarrouilhe D, Argibay JA, Herve JC: 5-HT4 and 5-HT2 receptors antagonistically influence gap junctional coupling between rat auricular myocytes. J Mol Cell Cardiol 2010;48:220-229.
9. Wang SH, Zhang ZJ, Guo YJ, Teng GJ, Chen BA: Decreased expression of serotonin 1A receptor in the dentate gyrus in association with chronic mild stress: A rat model of post-stroke depression. Psychiatry Res 2009;170:245-251.
10. Lucki I: The spectrum of behaviors influenced by serotonin. Biol Psychiatry 1998;44:151-162.
11. McAllister-Williams RH, Ferrier IN, Young AH: Mood and neuropsychological function in depression: The role of corticosteroids and serotonin. Psychol Med 1998;28:573-584.
12. Xie H, Han F, Shi X: Single-prolonged stress induce changes of CaM/CaMKIIalpha in the rats of dorsal raphe nucleus. Neurochem Res 2012;37:1043-1049.
13. Spannuth BM, Hale MW, Evans AK, Lukkes JL, Campeau S, Lowry CA: Investigation of a central nucleus of the amygdala/dorsal raphe nucleus serotonergic circuit implicated in fear-potentiated startle. Neuroscience 2011;179:104-119.
14. Curran KP, Chalasani SH: Serotonin circuits and anxiety: What can invertebrates teach us? Invert Neurosci 2012;12:81-92.
15. van Praag HM: Can stress cause depression? Prog Neuropsychopharmacol Biol Psychiatry 2004;28:891- 907.
16. Canli T, Congdon E, Gutknecht L, Constable RT, Lesch KP: Amygdala responsiveness is modulated by tryptophan hydroxylase-2 gene variation. J Neural Transm (Vienna) 2005;112:1479-1485.
17. Pilar-Cuellar F, Vidal R, Pazos A: Subchronic treatment with fluoxetine and ketanserin increases hippocampal brain-derived neurotrophic factor, beta-catenin and antidepressant-like effects. Br J Pharmacol 2012;165:1046-1057.
18. Sarnyai Z, Sibille EL, Pavlides C, Fenster RJ, McEwen BS, Toth M: Impaired hippocampal-dependent learning and functional abnormalities in the hippocampus in mice lacking serotonin(1A) receptors. Proc Natl Acad Sci U S A 2000;97:14731-14736.
19. Shishkina GT, Kalinina TS, Dygalo NN: Effects of swim stress and fluoxetine on 5-HT1A receptor gene expression and monoamine metabolism in the rat brain regions. Cell Mol Neurobiol 2012;32:787-794.
20. Burke TF, Advani T, Adachi M, Monteggia LM, Hensler JG: Sensitivity of hippocampal 5-HT1A receptors to mild stress in BDNF-deficient mice. Int J Neuropsychopharmacol 2013;16:631-645.
21. Liu C, Zhang X, Zhou JX, Wei W, Liu DH, Ke P, Zhang GF, Cai GJ, Su DF: The protective action of ketanserin against lipopolysaccharide-induced shock in mice is mediated by inhibiting inducible NO synthase expression via the MEK/ERK pathway. Free Radic Biol Med 2013;65:658-666.
22. Wang H, Zuo D, He B, Qiao F, Zhao M, Wu Y: Conditioned fear stress combined with single-prolonged stress: A new PTSD mouse model. Neurosci Res 2012;73:142-152.
23. Cohen H, Kaplan Z, Koresh O, Matar MA, Geva AB, Zohar J: Early post-stressor intervention with propranolol is ineffective in preventing posttraumatic stress responses in an animal model for PTSD. Eur Neuropsychopharmacol 2011;21:230-240.
24. Li XM, Su F, Ji MH, Zhang GF, Qiu LL, Jia M, Gao J, Xie Z, Yang JJ: Disruption of hippocampal neuregulin 1-ErbB4 signaling contributes to the hippocampus-dependent cognitive impairment induced by isoflurane in aged mice. Anesthesiology 2014;121:79-88.
25. Lairez O, Calise D, Bianchi P, Ordener C, Spreux-Varoquaux O, Guilbeau-Frugier C, Escourrou G, Seif I, Roncalli J, Pizzinat N, Galinier M, Parini A, Mialet-Perez J: Genetic deletion of MAO-A promotes serotonin-dependent ventricular hypertrophy by pressure overload. J Mol Cell Cardiol 2009;46:587-595.
26. Yang Y, Gao K, Hu Z, Li W, Davies H, Ling S, Rudd JA, Fang M: Autophagy upregulation and apoptosis downregulation in DAHP and triptolide treated cerebral ischemia. Mediators Inflamm 2015;2015:120198.
27. Dill MJ, Shaw J, Cramer J, Sindelar DK: 5-HT1A receptor antagonists reduce food intake and body weight by reducing total meals with no conditioned taste aversion. Pharmacol Biochem Behav 2013;112:1-8.
28. Liu C, Zhang GF, Song SW, Cai GJ, Liu WH, Miao CY, Su DF: Effects of ketanserin on endotoxic shock and baroreflex function in rodents. J Infect Dis 2011;204:1605-1612.
29. Peng Z, Zhang R, Wang H, Chen Y, Xue F, Wang L, Yang F, Liu L, Kuang F, Tan Q: Ziprasidone ameliorates anxiety-like behaviors in a rat model of PTSD and up-regulates neurogenesis in the hippocampus and hippocampus-derived neural stem cells. Behav Brain Res 2013;244:1-8.
30. Libert S, Pointer K, Bell EL, Das A, Cohen DE, Asara JM, Kapur K, Bergmann S, Preisig M, Otowa T, Kendler KS, Chen X, Hettema JM, van den Oord EJ, Rubio JP, Guarente L: SIRT1 activates MAO-A in the brain to mediate anxiety and exploratory drive. Cell 2011;147:1459-1472.
31. Ter Horst JP, Carobrez AP, van Der Mark MH, de Kloet ER, Oitzl MS: Sex differences in fear memory and extinction of mice with forebrain-specific disruption of the mineralocorticoid receptor. Eur J Neurosci 2012;36:3096-3102.
32. Verma M, Bali A, Singh N, Jaggi AS: Investigating the role of nisoldipine in foot-shock-induced post-Traumatic stress disorder in mice. Fundam Clin Pharmacol 2016;30:128-136.
33. Xing S, Zhang Y, Li J, Zhang J, Li Y, Dang C, Li C, Fan Y, Yu J, Pei Z, Zeng J: Beclin 1 knockdown inhibits autophagic activation and prevents the secondary neurodegenerative damage in the ipsilateral thalamus following focal cerebral infarction. Autophagy 2012;8:63-76.
34. Banares S, Zeh K, Krajewska M, Kermer P, Baribault H, Reed JC, Krajewski S: Novel pan-neuronal Cre-Transgenic line for conditional ablation of genes in the nervous system. Genesis 2005;42:6-16.
35. Hafner M, Wenk J, Nenci A, Pasparakis M, Scharffetter-Kochanek K, Smyth N, Peters T, Kess D, Holtkotter O, Shephard P, Kudlow JE, Smola H, Haase I, Schippers A, Krieg T, Muller W: Keratin 14 Cre transgenic mice authenticate keratin 14 as an oocyte-expressed protein. Genesis 2004;38:176-181.
36. Cacioppo JA, Koo Y, Lin PC, Osmulski SA, Ko CD, Ko C: Generation of an estrogen receptor beta-iCre knock-in mouse. Genesis 2016;54:38-52.
37. Xiang M, Zhou W, Gao D, Fang X, Liu Q: Inhibitor of apoptosis protein-like protein-2 as a novel serological biomarker for breast cancer. Int J Mol Sci 2012;13:16737-16750.
38. Shi: Activity of the 5-HT1A receptor is involved in the alteration of glucocorticoid receptor in hippocampus and corticotropin-releasing factor in hypothalamus in SPS rats. Int J Mol Med 2009;24:.
39. Liu D, Xiao B, Han F, Luo F, Wang E, Shi Y: Changes in 5-HT1A receptor expression in the oculomotor nucleus in a rat model of post-Traumatic stress disorder. J Mol Neurosci 2013;49:360-368.
40. Leonard BE: The HPA and immune axes in stress: The involvement of the serotonergic system. Eur Psychiatry 2005;20: 302-306.
41. Bordukalo-Niksic T, Mokrovic G, Stefulj J, Zivin M, Jernej B, Cicin-Sain L: 5HT-1A receptors and anxiety-like behaviours: studies in rats with constitutionally upregulated/downregulated serotonin transporter. Behav Brain Res 2010;213:238-245.
42. Blazevic S, Colic L, Culig L, Hranilovic D: Anxiety-like behavior and cognitive flexibility in adult rats perinatally exposed to increased serotonin concentrations. Behav Brain Res 2012;230:175-181.
43. Deakin J: The role of serotonin in depression and anxiety. Eur Psychiatry 1998;13:S57s-63s.
44. Fox MA, French HT, LaPorte JL, Blackler AR, Murphy DL: The serotonin 5-HT(2A) receptor agonist TCB-2: A behavioral and neurophysiological analysis. Psychopharmacology (Berl) 2010;212:13-23.
45. Chen L, Chen G, Guo Y, Liu L, Xiao L, Fan W, Shi B, Qian Y: Ketanserin, a serotonin 2A receptor antagonist, alleviates ischemia-related biliary fibrosis following donation after cardiac death liver transplantation in rats. Liver Transpl 2014;20:1317-1326.
46. Holmes A, Yang RJ, Lesch KP, Crawley JN, Murphy DL: Mice lacking the serotonin transporter exhibit 5-HT(1A) receptor-mediated abnormalities in tests for anxiety-like behavior. Neuropsychopharmacology 2003;28:2077-2088.
47. Garcia-Garcia AL, Meng Q, Richardson-Jones J, Dranovsky A, Leonardo ED: Disruption of 5-HT1A function in adolescence but not early adulthood leads to sustained increases of anxiety. Neuroscience 2016;321:210- 221.
48. Kurrasch-Orbaugh DM, Parrish JC, Watts VJ, Nichols DE: A complex signaling cascade links the serotonin2A receptor to phospholipase A2 activation: The involvement of MAP kinases. J Neurochem 2003;86:980-991.
49. Franklin JM, Carrasco GA: Cannabinoid receptor agonists upregulate and enhance serotonin 2A (5-HT(2A)) receptor activity via ERK1/2 signaling. Synapse 2013;67:145-159.